Ingel Therapeutics, Inc
InGel Therapeutics is Harvard-spinoff, regenerative medicine biotech leveraging novel neuroprotective mechanisms to stop retinal degeneration. Our beachhead indication is Retinitis Pigmentosa, with future expansion opportunities which include Dry-AMD and Glaucoma.
7-day free trial · no credit card
Verified contacts
4
available on Kipplo
LinkedIn employees
8
1 to 10 range
Open roles
—
no listings
Distinct roles
4
indexed titles
Tech stack
1
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 4 verified contacts at Ingel Therapeutics, Inc
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
4 contacts with verified email or phone · masked until revealed.
- RW
Rita Watkins
Angel Investor · General Business & Management
EmailPhone - DS
Deepti Singh
Founder and Chief Scientific Officer · Other
EmailPhone - PJ
Patrick Jiang
Co-founder and Chief Business Officer · Other
EmailPhone - PC
Pierre Colombe Dromel
Co-founder and CEO · Other
EmailPhone
Showing 4 of 4 verified contacts
Top roles at Ingel Therapeutics, Inc
4 distinct titles indexed · top 4 shown.
- 1angel investor
- 1co-founder and ceo
- 1co-founder and chief business officer
- 1founder and chief scientific officer
Sign up to unlock all 4 contacts at Ingel Therapeutics, Inc
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 4 verified contacts at Ingel Therapeutics, Inc
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.